Compare ORLY & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORLY | COR |
|---|---|---|
| Founded | 1957 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8B | 68.5B |
| IPO Year | 1993 | N/A |
| Metric | ORLY | COR |
|---|---|---|
| Price | $92.88 | $352.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 13 |
| Target Price | $110.63 | ★ $380.54 |
| AVG Volume (30 Days) | ★ 6.2M | 1.2M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | 9.57 | ★ 18.64 |
| EPS | 2.97 | ★ 8.33 |
| Revenue | $17,781,992,000.00 | ★ $325,777,775,000.00 |
| Revenue This Year | $8.43 | $7.19 |
| Revenue Next Year | $6.79 | $6.19 |
| P/E Ratio | ★ $32.57 | $39.61 |
| Revenue Growth | 6.42 | ★ 7.45 |
| 52 Week Low | $85.55 | $237.71 |
| 52 Week High | $108.72 | $377.54 |
| Indicator | ORLY | COR |
|---|---|---|
| Relative Strength Index (RSI) | 37.83 | 52.26 |
| Support Level | $96.68 | $328.01 |
| Resistance Level | $99.20 | $366.15 |
| Average True Range (ATR) | 2.19 | 10.38 |
| MACD | -0.40 | -0.65 |
| Stochastic Oscillator | 5.09 | 66.75 |
O'Reilly is an aftermarket automotive parts retailer in the United States and Mexico with more than $16 billion in annual sales. The company operates over 6,000 domestic stores and serves both the do-it-yourself (about 50% of sales) and professional (47% of sales) end markets. O'Reilly differentiates itself by providing quality service to its customers throughout the entirety of the vehicle diagnosis and purchasing process. Furthermore, the firm boasts an impressive hub-and-spoke distribution network designed to provide its localized store base with ample aftermarket part availability across a variety of vehicle makes and models.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.